Bone Biologics Corp
BBLG
Company Profile
Business description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Contact
2 Burlington Woods Drive
Suite 100
BurlingtonMA01803
USAT: +1 781 552-4452
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
2
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,826.70 | 48.80 | 0.56% |
CAC 40 | 7,902.25 | 23.79 | 0.30% |
DAX 40 | 24,456.81 | 92.75 | -0.38% |
Dow JONES (US) | 44,676.74 | 218.44 | 0.49% |
FTSE 100 | 8,975.66 | 108.64 | 1.23% |
HKSE | 24,028.37 | 136.05 | 0.57% |
NASDAQ | 20,600.92 | 10.42 | -0.05% |
Nikkei 225 | 39,646.36 | 174.92 | -0.44% |
NZX 50 Index | 12,760.20 | 8.41 | -0.07% |
S&P 500 | 6,275.25 | 11.99 | 0.19% |
S&P/ASX 200 | 8,589.20 | 50.60 | 0.59% |
SSE Composite Index | 3,509.68 | 16.63 | 0.48% |